This is the authors' abstract. We don't add key points for this paper.
Genetic testing platforms such as chromosomal microarray analysis and next generation sequencing often detect genetic variants of incomplete penetrance and variable expressivity. The difficulty to determine the exact genotype-phenotype correlations and to predict the clinical outcome is enhanced when these variants are detected in the prenatal setting. In this article, we suggest 10 important points that may assist the clinician in providing genetic counseling in such cases. The first step should be determining whether the variant is classified as a well-established syndrome, as in such cases little additional investigation is needed regarding related phenotypes, penetrance and rate of de novo vs inherited cases. Several curated databases provide relevant information, including DECIPHER (https://decipher.sanger.ac.uk/), ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/), as well as recently published reviews.1 The date of last-related review must be noted, to ensure no new conflicting data have emerged. In addition, human genomic variant interpretation tools such as VarSome (https://varsome.com/) or Franklin (https://franklin.genoox.com/clinical-db/home) can be helpful. Penetrance estimation formula is based on three main parameters: frequency of the variant in affected cohorts, its frequency in the general population and lifetime baseline risk for the phenotype.2 Obviously, the accuracy of the estimated penetrance strongly depends on the sample size. For many variants the reported cohorts of affected and unaffected individuals are not large enough, hence the calculation of the penetrance is not optimal.2 In addition, ascertainment bias must be taken into an account, as well as the uncertain health status of individuals used as controls. This question should be examined at the level of both the affected gene and the specific variant. Tolerance of a given gene to loss of function effects can be measured by pLI (probability of being loss of function [LoF] intolerant), calculated based on the difference between observed vs expected number of protein-truncating variants in a specific gene.3 Haploinsufficiency score (HI) is another widely used predictive modality. The effects of a specific variant on gene function can be examined by various approaches. Sequencing null variants (eg nonsense, frameshift, canonical ±1 or 2 splice sites, initiation codon, single exon or multi-exon deletion), copy number losses, or gene-truncating copy number gains can be assumed to disrupt gene function, with specific considerations.4 In addition, clinical significance and phenotypic effects of gene-disrupting mutations can be evaluated by their frequency in large population samples. While variants that are prevalent in databases of healthy individuals are usually not assumed to be causative, variants that are absent or of very low prevalence are implicated as causative. The use of programs such as pathogenicity-predictive scoring (eg TraP-score http://trap-score.org/) and conservation scores can assist in estimating the effects of the variant on the involved gene. Finally, functional in vitro and in vivo studies examining the effects of the variant on the gene or gene product should be sought, since these are considered the most well-established evidence of pathogenicity.4 Determining whether the detected variant is inherited or represents a de novo mutation is of significance for clinical counseling and reproductive planning. In the case of an inherited finding, testing numerous family members can provide a better estimation of the penetrance and expressivity of the specific variant in the family. In addition, diagnosis of genomic variant within segregation analysis in parents and other family members might explain minor clinical symptoms, such as attention deficit disorder or learning difficulties. Finally, as the recurrence risk for de novo variants is minimal, whereas inherited findings can be expected to recur in 50% of future pregnancies, potentially leading to prenatal and/or pregestational diagnostic workup, this knowledge can affect the decisions in the current pregnancy. Evidence suggests that females may be less vulnerable to the effects of large copy number variants than males are. A large study comparing cohorts of clinically affected patients carrying variants with incomplete penetrance and variable expressivity with patients with syndromic disorders has shown a higher proportion of male patients among those with phenotypic variation.5 The authors suggested that weak deleterious mutations on the single X chromosome of male patients might predispose males to express abnormal phenotypes at a lower mutation burden. The spectrum of clinical manifestations associated with some variants can range from asymptomatic carriers to severe phenotypes, such as severe intellectual disability. Databases mentioned above (DECIPHER and ClinVar) can also be used for determination of the range of various phenotypes. Data regarding the percentage of patients expressing the associated phenotypes can assist the couple to estimate the risks for the fetus; however, such data are often missing, partial or inaccurate. Phenotypic variability of genetic diseases can be influenced by numerous factors, such as environmental effects, modifier genes and second-hit chromosomal imbalances.6 Classic examples of environmental contribution to the phenotype of monogenic diseases include dietary intake of phenylalanine in phenylketonuria, or the association between smoking and lung disease in α-1 antitrypsin deficiency. Examples for modifier genes include the incomplete penetrance of congenital scoliosis in patients with proximal 16p11.2 microdeletions encompassing the TBX6 gene, related to the concomitant presence of a common haplotype in the second TBX6 gene allele, or the phenotypic diversity of X-linked retinitis pigmentosa caused by mutations in RPGR explained by polymorphic variation of RPGRIP1L and IQCB1.7 An example of the “two-hit” hypothesis is the increased amount of additional rare copy number variations in patients with 22q11.2 deletion and intellectual disability, compared with normal carriers,8 or the enrichment of second-site variants in children with more severe phenotype in genomic disorders of incomplete penetrance and variable expressivity.5 The counselor should ascertain in advance the possibilities and availability of a potential treatment for the disorder or expected symptoms and present this to the couple. The reproductive decisions may differ in the case of treatable phenotypes (such as cardiac structural defects which can be surgically corrected, or renal disease which can be treated by kidney transplant) vs untreatable disorders such as severe brain anomaly, intellectual disability, or autism spectrum disorders. Numerous additional parameters that may potentially affect parental decisions should be taken into an account. Is this the first pregnancy? Was the pregnancy conceived spontaneously or following fertility treatments? How many children does the couple have, and are the children healthy? Is there any history of spontaneous miscarriage or previous pregnancy terminations? Is there any family history of neurodevelopmental disorders or congenital anomalies? What is the maternal age? What is the gestational age and what are the couple’s religious beliefs and moral position regarding pregnancy termination? All of these might have profound effects on the counseling, as well on the consequent decisions of the couple.9 Understanding the information communicated during genetic counseling can be extremely challenging for the patients, due to the complexity of genomic testing and the variety of continuously evolving tests. This difficulty is further highlighted in cases where variants with incomplete penetrance and variable expressivity are detected, due to the possibility of numerous scenarios and varying strength of evidence. The counselor must ensure that the patients understand the complex concepts of penetrance, range of possible phenotypes and options for future prenatal vs pregestational diagnosis. Visual aids and schematic illustrations can be used, as well as repeat counseling and acquisition of additional professional opinions. Preferably, counseling should be conducted in the presence of the spouse or other supportive family member, and accompanied by a social worker when needed. In summary, numerous factors should be taken into an account while providing prenatal counseling for variants with incomplete penetrance and variable expressivity, requiring varying approaches on a case-by-case basis.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Maya et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: